Bioventrix

BioVentrix, Inc. a specialty medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies. BioVentrix technologies aim to improve cardiac function by directly addressing LV dilation. The BioVentrix Revivent System is designed to support a minimally invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy. The procedure uses myocardial micro-anchor implants to reconstruct the dilated left ventricle to produce a more efficient chamber. BioVentrix offers benefits to all stakeholders in heart failure: Patient – improved survival and QOL by treating the underlying cause of HF less invasively Payor – reduced hospitalizations and avoidance of more expensive, highly invasive procedures like transplant and LVAD Provider – become a pioneer in heart failure and offer unique solutions to your patients, in the growing and most expensive disease state in the world